All Stories

  1. Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma
  2. Immunomodulatory effects of Diospyros peregrina fruit preparation (DFP) in non-small cell lung cancer (NSCLC) by utilizing dendritic cell-mediated antigen presentation and T helper (TH) cell differentiation
  3. Prediction of maternal and foetal outcomes among patients with preeclampsia using circulatory biomarkers (MMP-9 & ST2) - A prospective cohort study
  4. Fathoming the Role of Semaglutide in Obesity Therapeutics
  5. Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC)
  6. Differential Expression of Caveolin-3, Suppression of Tumorigenicity 2, and Growth Differentiation Factor-15 Genes and Their Association with Acute Myocardial Infarction: A Cross-Sectional Study in a Multi-Specialty Hospital in Tamil Nadu
  7. Role of Diospyros peregrina fruit preparation in suppressing regulatory T (Treg) cells in the tumor microenvironment of breast and lung cancer
  8. EVALUATION OF ADENOVIRAL VECTOR-BASED VACCINES FOR PREVENTION OF COVID-19 – AN OVERVIEW
  9. Extent of knowledge and attitudes on plagiarism among undergraduate medical students in South India - a multicentre, cross-sectional study to determine the need for incorporating research ethics in medical undergraduate curriculum
  10. Usefullness of MicroRNAs in Predicting the Clinical Outcome of Patients with Acute Myocardial Infarction During Follow-Up: A Systematic Review
  11. Efficacy of pharmacological interventions in COVID‐19: A network meta‐analysis
  12. Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review
  13. Alirocumab in Post ACS Patients - Saving Lives at a Premium
  14. A Review of The Contribution of Gut-Dependent Microbiota Derived Marker, Trimethylamine N-oxide (TMAO), in Coronary Artery Disease
  15. Long Term Prognostic Utility of Matrix Metalloproteinase-9 in Patients with Acute Coronary Syndrome - A Systematic Review
  16. Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges
  17. Novel and Re-emerging Zoonotic Viral Diseases in India during Last Two Decades: An Overview
  18. Avaliação da Senescência de Células Sanguíneas Mononucleares Periféricas e na Disfunção Endotelial entre Adultos com Alto Risco Cardiovascular
  19. The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy
  20. Novel approaches in the treatment of diabetic cardiomyopathy
  21. Prognostic role of soluble ST2 in acute coronary syndrome with diabetes
  22. Effect of metformin on exercise capacity in metabolic syndrome
  23. Authors reply to “No, we are not—we keep forgetting the right ventricle”
  24. Do ANGPTL-4 and galectin-3 reflect the severity of coronary artery disease?
  25. Homocysteine-Is there any role in Coronary Heart Disease?
  26. A peek into the drug development scenario of endometriosis – A systematic review
  27. SCARB1 rs5888 c.1050C>T Polymorphism and the Risk of Hypercholesterolemia and Myocardial Infarction in Indian Tamil Population
  28. End points in heart failure—are we doing it right?
  29. Molecular analysis of the LDLR gene in coronary artery disease patients from the Indian population
  30. Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial
  31. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition—The Dream of Translational Medicine
  32. GDF 15 - A Novel Biomarker in the Offing for Heart Failure
  33. Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study
  34. Riociguat: Something new in pulmonary hypertension therapeutics?
  35. Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome
  36. Pattern of Adverse Drug Reactions Reported with Cardiovascular Drugs in a Tertiary Care Teaching Hospital
  37. Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?
  38. Looking into the Crystal Ball—Upcoming Drugs for Dyslipidemia
  39. Novel drug targets in clinical development for heart failure
  40. Pharmacovigilance for psychiatrists: An introduction
  41. Clinical Trial Endpoints in Breast Cancer
  42. Assessment of Arterial Stiffness Index in Hypertensive Patients in Relation to Their Treatment Status Attending a Tertiary Care Center in South India
  43. Noninvasive Nanodiagnostics for Cancer
  44. New and Emerging Drug Molecules Against Obesity
  45. Newer antipsychotics and upcoming molecules for schizophrenia
  46. Globalization of Clinical Trials – Where are We Heading?
  47. Pharmacogenomics of Autoimmune Diseases
  48. The dawn of hedgehog inhibitors: Vismodegib
  49. Pharmacogenomics in Type 2 Diabetes Mellitus and Metabolic Disorders
  50. Clinical trials in India: Where do we stand globally?
  51. Belatacept: A worthy alternative to cyclosporine?
  52. Authors′ reply
  53. Effect of anti-tuberculosis therapy on polymorphic drug metabolizing enzyme CYP2C9 using phenytoin as a probe drug